Skip to main content
. 2021 Jan 1;18(1):137–149. doi: 10.7150/ijms.48393

Table 4.

Drug concentrations for combination treatment

NB cell line/drug Drug Kelly IMR-32 SK-N-BE(2)
Dasatinib/Rapamycin Dasatinib [µM] 5.00 0.05 20.00
Rapamycin [µM] 2.00 0.13 5.00
Dasatinib/Torin-2 Dasatinib [µM] 1.50 1.00 12.50
Torin-2 [nM] 9.00 6.00 15.00
Irinotecan (SN-38)/
Temozolomide (TMZ)
Irinotecan [nM] 1.00 0.40 -
Temozolomide [µM] 225.00 120.00 -